Product Name: Human GM-CSF2RA Antibody (Mavrilimumab, Research Use)
Catalog Number: NBR-0187
Target Name: GM-CSF2RA
Trade Name: Mavrilimumab
Antibody Drug Description: Mavrilimumab is a human monoclonal antibody[1] that inhibits human granulocyte macrophage colony-stimulating factor receptor (GM-CSF-R). Appearance: Transparent Liquid
Molecular Weight: ~150kDa
CAS：N/A
Solubility: Water; PBS, TBS Buffer etc.
Expression System: CHO Expressed
Isotype of Ab: Ab. Isotype - IgG

  Gene Name: GM-CSF2RA
Synonyms: alphaGMR; CD116; CSF2R
Target Description: CSF2RA (Colony Stimulating Factor 2 Receptor Subunit Alpha) is a Protein Coding gene. Diseases associated with CSF2RA include Surfactant Metabolism Dysfunction, Pulmonary, 4 and Hereditary Pulmonary Alveolar Proteinosis. Among its related pathways are RAF/MAP kinase cascade and Interleukin-2 family signaling. Gene Ontology (GO) annotations related to this gene include signaling receptor activity and cytokine receptor activity. An important paralog of this gene is IL3RA.
Ensembl: ENSG00000198223
Uniprot: P15509